- Solid Tumors
- Pipeline Molecules
- Alliance Partners
Our mission is to provide healthcare professionals with unbiased clinical research information, easily.
Currently, you can access the following clinical trials being conducted worldwide:
Clinicaltrials.gov identifier NCT03942302
Recruitment Status Recruiting
First Posted May 8, 2019
Last update posted May 8, 2019
Validate a simple clinical tool to evaluate physical activity (the question "How many minutes does it walk per day?" Or equivalent), compared to the rest of the collected physical activity data (PROactive questionnaire and objective physical activity data by means of an accelerometer record) in patients with COPD.
Observational, national and multicenter epidemiological study in adult patients with COPD that will take place in the consultations of specialists in pneumology under conditions of usual clinical practice and that will be developed in two visits per patient.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, , Learn About Clinical Studies.-->
Adult patients, ≥ 40 years.
- Patients diagnosed with COPD according to the GOLD criteria: FEV1 / FVC
postbronchodilator <0.70 in a spirometry performed in the last 12 months. - Smokers or ex-smokers of ≥10 pack-years. - Patients with a minimum age in the diagnosis of COPD of at least 6 months. - Patients who accept their participation in the study and who have given their informed consent (IC) in writing to participate in it. Exclusion Criteria: - Patients whose clinical history data are not available. - Patients unable to understand the study questionnaires. - Patients with physical limitation (not caused by the respiratory disease, eg disability, orthopedic limitation, etc.) and / or psychic that prevents the proper conduct of the study. - Patients who present a moderate or severe exacerbation of COPD in the month prior to inclusion. - Patients with other chronic respiratory diseases other than COPD (such as cystic fibrosis, bronchiectasis of origin other than COPD, neoplasia, pneumonia). - Patients with serious cardiovascular or neurological diseases. - Hospital admission for any reason in the month prior to inclusion.
Contact: Elisa Simón 910888877 email@example.com
Contact: Ester Salmerón 93 2172115 firstname.lastname@example.org
Study Director: Ferran Morell Fundacio Catalana de Pneumologia